Position in ABSI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,483,381
+$3,469,849 QoQ
Shares Held
386,832
+14.5% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ABSI ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,483,381 | 386,832 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,013,532 | 337,844 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,188,741 | 340,614 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,010,254 | 332,321 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $725,940 | 282,468 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $561,477 | 223,697 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $583,378 | 222,664 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $855,705 | 224,007 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $880,152 | 285,764 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $261,376 | 46,017 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $307,771 | 73,279 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $81,642 | 61,850 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $95,729 | 62,980 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $297,763 | 170,151 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $361,620 | 172,200 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $545,386 | 174,245 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $418,454 | 126,041 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,170,276 | 138,823 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $238,291 | 29,060 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $302,100 | 25,976 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||